Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (401-410 of 682) with videos related to

Pageof 69
Sort By:
Antimicrobial Agents and Chemotherapy|December 7, 2023
A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjectsMaría Patricia Hernández-Mitre, Steven C Wallis, Elizabeth E Morgan, et al.
Pharmaceutical Research|November 30, 2021
Micafungin Population PK Analysis in Healthy and Septic Pigs: Can the Septic Porcine Model Predict the Micafungin PK in Septic Patients?Nicolas Garbez, Litaty C Mbatchi, Guillaume Louart, et al.
Frontiers in Pharmacology|June 30, 2020
Conventional Pig as Animal Model for Human Renal Drug Excretion Processes: Unravelling the Porcine Renal Function by Use of a Cocktail of Exogenous MarkersLaura Dhondt, Siska Croubels, Peter De Paepe, et al.
Journal of Pharmaceutical Analysis|January 1, 2019
Recovery rates of combination antibiotic therapy using <i>in vitro</i> microdialysis simulating <i>in vivo</i> conditionsJayesh A Dhanani, Suzanne L Parker, Jeffrey Lipman, et al.
Critical Care (London, England)|November 30, 2014
Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compoundsAndrew A Udy, Paul Jarrett, Janine Stuart, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile NeutropeniaFekade Bruck Sime, Uwe Hahn, Morgyn S Warner, et al.
Pediatric Research|May 23, 2021
Microsampling to support pharmacokinetic clinical studies in pediatricsYarmarly Guerra Valero, Tavey Dorofaeff, Lisa Parker, et al.
Biomedical Chromatography : BMC|June 18, 2017
A validated UHPLC-MS/MS method for the measurement of riluzole in plasma and myocardial tissue samplesSuzanne L Parker, Yarmarly C Guerra Valero, Jeffrey Lipman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 13, 2019
Diagnostic and medical needs for therapeutic drug monitoring of antibioticsClaude Mabilat, Marie Francoise Gros, David Nicolau, et al.
Clinical Pharmacokinetics|March 7, 2020
Development of Population and Bayesian Models for Applied Use in Patients Receiving CefepimeJiajun Liu, Michael Neely, Jeffrey Lipman, et al.
Pageof 69

Showing results (401-410 of 682) with videos related to

Sort By:
Pageof 69
Antimicrobial Agents and Chemotherapy|December 7, 2023
A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjectsMaría Patricia Hernández-Mitre, Steven C Wallis, Elizabeth E Morgan, et al.
Pharmaceutical Research|November 30, 2021
Micafungin Population PK Analysis in Healthy and Septic Pigs: Can the Septic Porcine Model Predict the Micafungin PK in Septic Patients?Nicolas Garbez, Litaty C Mbatchi, Guillaume Louart, et al.
Frontiers in Pharmacology|June 30, 2020
Conventional Pig as Animal Model for Human Renal Drug Excretion Processes: Unravelling the Porcine Renal Function by Use of a Cocktail of Exogenous MarkersLaura Dhondt, Siska Croubels, Peter De Paepe, et al.
Journal of Pharmaceutical Analysis|January 1, 2019
Recovery rates of combination antibiotic therapy using <i>in vitro</i> microdialysis simulating <i>in vivo</i> conditionsJayesh A Dhanani, Suzanne L Parker, Jeffrey Lipman, et al.
Critical Care (London, England)|November 30, 2014
Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compoundsAndrew A Udy, Paul Jarrett, Janine Stuart, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile NeutropeniaFekade Bruck Sime, Uwe Hahn, Morgyn S Warner, et al.
Pediatric Research|May 23, 2021
Microsampling to support pharmacokinetic clinical studies in pediatricsYarmarly Guerra Valero, Tavey Dorofaeff, Lisa Parker, et al.
Biomedical Chromatography : BMC|June 18, 2017
A validated UHPLC-MS/MS method for the measurement of riluzole in plasma and myocardial tissue samplesSuzanne L Parker, Yarmarly C Guerra Valero, Jeffrey Lipman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 13, 2019
Diagnostic and medical needs for therapeutic drug monitoring of antibioticsClaude Mabilat, Marie Francoise Gros, David Nicolau, et al.
Clinical Pharmacokinetics|March 7, 2020
Development of Population and Bayesian Models for Applied Use in Patients Receiving CefepimeJiajun Liu, Michael Neely, Jeffrey Lipman, et al.
Pageof 69